VATEZOR Trademark Information

Trademark by Mitsubishi Pharma Corporation

Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease, vascular dementia, mild cognitive impairment, attention deficit hyperactive disorder, autism, glaucoma, and associated disorder of depression, parkinsonism and neurosis

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: VATEZOR
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
10/5/2012
Serial Number: 78332201
Filing Date: 11/24/2003
Registration Number: 2987268
Registration Date: 8/23/2005
Goods and Services: Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease, vascular dementia, mild cognitive impairment, attention deficit hyperactive disorder, autism, glaucoma, and associated disorder of depression, parkinsonism and neurosis
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 5/31/2005
Last Applicant/Owner:
Mitsubishi Pharma Corporation
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
10/5/2012
Correspondent Search:
Sarah Anne Keefe is a correspondent of VATEZOR trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on